Why it earned this rating
Our assessment
Growth Pathway 7 is Delaware Life's accessible-minimum 7-year accumulation FIA. The longer commitment funds typically more competitive caps and participation rates than the 5-year sibling.
The short version
If you want a 7-year FIA where you know your account value has a stated floor under it at maturity, Growth Pathway 7 is worth a close look. What makes it stand out is that the GMAV guarantee costs nothing and is not tied to a complex benefit base calculation — it is straightforward. What limits its appeal is that someone seeking maximum index upside or a built-in income stream will find better tools elsewhere.
Key facts
The full review
Is Delaware Life Growth Pathway 7 a Good Annuity?
Yes, for the right buyer. This is a good annuity for someone who wants 7-year accumulation potential with a genuine no-cost safety net under their balance. It is less attractive for someone who wants a short surrender period, prioritizes a built-in lifetime income stream, or is comparing against MYGAs where guaranteed rates may be simpler to evaluate.
Why Someone Would Buy This Annuity
The primary reason to buy Growth Pathway 7 is accumulation with a defined floor. The GMAV feature converts some of the uncertainty around index-linked crediting into a minimum outcome — at year seven, your account will be at least 121% of what you deposited (or 125% in a Precision Portfolio), assuming no withdrawals. The secondary reason is the breadth of index choices. Buyers who want to combine S&P 500 exposure with technology-sector (Invesco QQQ), dividend-focused (First Trust Capital Strength Barclays), or volatility-managed (Janus Henderson Adaptive Market Leaders, Franklin SG Select Advantage) allocations can do that inside one contract.
Who This Annuity Is Best For
I think Growth Pathway 7 works best for someone with true 7-year money who wants the index-participation upside of an FIA but wants a quantified floor rather than relying entirely on "your principal is protected." The GMAV makes the downside case concrete. It is also a reasonable fit for buyers who like the idea of a Precision Portfolio — a pre-set multi-index allocation — without having to rebalance themselves. It is a poor fit for someone who needs income during the accumulation phase, wants full liquidity, or is in their late 70s or early 80s and cannot absorb a 7-year lock-up.
What You're Really Buying Here
You are buying a 7-year insurance contract that credits interest based on the performance of selected indices while guaranteeing your principal and locking in gains annually. The real value is the combination of: (1) index-linked growth potential without direct market exposure, (2) a no-cost account value floor at the end of the surrender period, and (3) a Rate Lock option that fixes your cap or performance trigger rate for the full 7-year term. You are not buying market participation directly, and you are not buying income.
How the Core Feature Works
Growth Pathway 7 is a point-to-point crediting FIA. At the end of each contract year, the index-linked strategies compare the index value at that year's start and end. Gains up to the cap (or at the declared performance trigger rate) are credited to your account. Losses result in zero interest — not a reduction of principal.
The S&P 500 strategies illustrate the range: caps run from 7.15% to 9.65% depending on premium band (current as of April 2026), while performance trigger rates run from 5.90% to 7.65%. That means if the S&P 500 is positive by any amount, the trigger strategy credits a declared rate regardless of how high the index went. The QQQ strategies follow a similar structure with caps from 6.40% to 8.90%.
The Rate Lock strategies are notable: buyers can elect a 5-year or 7-year Rate Lock at issue that fixes the cap or performance trigger rate for the duration. This eliminates renewal risk during the lock period — your rate cannot be cut at annual renewal. The tradeoff is that you cannot reallocate until the Lock Period ends.
The GMAV (Guaranteed Minimum Account Value) is the product's defining no-cost feature. At the end of the 7-year surrender period, if your account value is below 121% of initial premium (less any withdrawals), Delaware Life increases your balance to that floor automatically. If you elected a Precision Portfolio and stayed in it through the benefit holding period, the floor rises to 125%. That is an annual compound equivalent of roughly 2.8%–3.6% — useful as a worst-case anchor but not the primary driver of your decision.
Why the Secondary Feature Matters
The secondary feature worth understanding is the Precision Portfolio option. Instead of selecting individual index strategies, buyers can allocate 100% of premium to a pre-configured multi-index portfolio at issue. Portfolio Option 1 is equity-tilted — it blends S&P 500 cap, S&P 500 trigger, Invesco QQQ, and Janus Henderson strategies with a small fixed account allocation. Portfolio Option 2 is volatility-managed — it emphasizes First Trust Capital Strength Barclays, Franklin SG Select Advantage, and the Janus Henderson index, which all use volatility control overlays.
The portfolio design matters because it unlocks the Enhanced GMAV: a 125% floor instead of 121% at year seven. That incremental 4 percentage points is meaningful over the hold period. The restriction is that any reallocation during the benefit holding period drops the Enhanced GMAV back to the standard 121% level, so buyers should be confident in the pre-set allocation before electing it.
Liquidity and Surrender Schedule
The 7-year non-rolling surrender schedule starts at 9% and declines by roughly 1 point per year. All payments made during the contract become surrender-charge-free at the end of year 7 simultaneously (non-rolling), which simplifies the timeline for buyers adding subsequent premiums. The MVA applies on top of surrender charges when you take more than your free amount, which can swing the effective penalty meaningfully depending on interest rate conditions at the time of withdrawal.
Free withdrawal access is 10% of total premiums in year 1 and 10% of prior anniversary account value in years 2+, with RMD exceptions handled cleanly. There are also waivers for nursing home confinement (after year 1, if purchased before age 76) and terminal illness. The bailout provision lets buyers surrender without charges if the renewal S&P 500 cap rate falls below the stated bailout threshold — a meaningful protection against rate deterioration on that particular strategy.
Fees and Tradeoffs
There are no product-level fees, no mortality and expense charges, and no administration charges. The contract itself has zero ongoing fee drag, which is one of the cleaner cost structures in the FIA market. The Rate Lock strategies carry a small spread cost embedded in the guarantee (not a separate line-item charge), and the Precision Portfolio allocation does not carry an extra fee either.
The tradeoff is structural: the index strategies limit your upside to caps or participation rates set by Delaware Life. Those rates are reset annually at renewal (unless you are in a Rate Lock strategy). Buyers need to understand that current illustrated rates are not guaranteed beyond the first year — rate cuts are possible and can happen.
Product snapshot
| Feature | Details |
| --- | --- |
| Product Type | Fixed Index Annuity (FIA) |
| Surrender Period | 7 years (non-rolling) |
| Surrender Schedule | 9%, 8%, 7%, 6%, 5%, 4%, 3%, 0% |
| Issue Ages | 18–85 |
| Minimum Premium | $10,000 (Q and NQ) |
| Subsequent Premiums | $500 minimum; total premium cap $1M without prior approval |
| Free Withdrawal | 10% of premiums (year 1); 10% of account value or RMD (years 2+) |
| Market Value Adjustment | Yes, on excess withdrawals during surrender period |
| GMAV (Standard) | 121% of initial premium at year 7 |
| GMAV (Enhanced — Precision Portfolio) | 125% of initial premium at year 7 |
| Index Menu | S&P 500, Invesco QQQ, First Trust Capital Strength Barclays 10%, Janus Henderson Adaptive Market Leaders, Franklin SG Select Advantage |
| Crediting Methods | 1-Year Point-to-Point (Cap), Performance Trigger, Participation Rate, Fixed Account |
| Rate Lock Option | 5-year or 7-year Rate Lock on Cap and Performance Trigger strategies at issue |
| No-Cost Features | GMAV, Precision Portfolios, Rate Lock, Bailout Provision |
| Living Benefit Rider | Not available |
| Death Benefit | Greater of account value or surrender value |
| Waivers | Nursing Home (after year 1, pre-age 76); Terminal Illness (after year 1, pre-age 70) |
| State Availability | All states except New York |
Carrier snapshot
Delaware Life Insurance Company has a long history in the fixed index annuity space — the company traces the launch of the first FIA to its predecessor entity (then Keyport Life) in February 1995. The company was rebranded as Delaware Life in 2013 and is headquartered in Zionsville, Indiana. Financial strength ratings as of December 2024 are A- from A.M. Best (Excellent, 4th highest of 16), A- from Standard and Poor's (7th of 21), and A- from Fitch (7th of 19). Those three A- ratings are a consistent signal of solid financial strength, though not at the very top tier. Delaware Life is not licensed in New York.
Final take
Growth Pathway 7 is a well-constructed accumulation FIA that earns its place in the 7-year peer group by doing something most competitors skip: it gives buyers a stated minimum account value at maturity at no charge. The Rate Lock feature adds another dimension of certainty that I think is underappreciated — locking a cap rate for 7 years removes the annual renewal negotiation for buyers who want predictability. The index menu is broad without being unwieldy.
Where I would push back is on the proprietary volatility-controlled indices. The Janus Henderson Adaptive Market Leaders, Franklin SG Select Advantage, and First Trust Capital Strength Barclays strategies all use volatility control overlays that tend to mute performance in strong equity markets. Participation rates of 70%–135% on these indices sound attractive, but the underlying indices are designed to stay within volatility targets, which can limit gains when markets run. Buyers who care most about raw index upside should focus on the S&P 500 and QQQ strategies with caps.
Overall, if a 7-year commitment fits the buyer's timeline and the GMAV floor provides meaningful peace of mind, Growth Pathway 7 is a good choice in its category.